Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

NCT03081858

Conditions
Bladder Cancer, Bladder Cancer Cell Transitional, Carcinoma, +17 more
Locations
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
  • Trovare Clinical Research Bakersfield, California, United States
  • Tower Urology Los Angeles, California, United States
  • Chesapeake Urology Associates Hanover, Maryland, United States
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

NCT04068896

Conditions
Adnexal Diseases, Bladder Cancer, Bronchial Neoplasms, +69 more
Locations
  • NGM Clinical Study Site Tucson, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sacramento, California, United States
View all 20 locations
View Trial Details
Completed

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

NCT04383938

Conditions
Advanced Solid Tumor, Bladder Cancer, Bronchial Neoplasms, +32 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

CD155 in Bladder Cancer

NCT03789682

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

NCT02365766

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • IU Health Central Indiana Cancer Center Indianapolis, Indiana, United States
  • Community Regional Cancer Care Indianapolis, Indiana, United States
  • St. Vincent Hospital Indianapolis, Indiana, United States
View Trial Details

Related conditions